Tag:

counterfeiting

Latest Headlines

Latest Headlines

New powers, new name for China's drug regulator

China's SFDA is no more. The agency has gotten a promotion and a new name: the China Food and Drug Administration (CDFA).

China revamp boosts powers of drug manufacturing regulators

China's oversight of drug manufacturing is often faulted for being weak and ineffective and the country is often considered the capital of drug counterfeiting.

Pfizer, Glaxo, others give Interpol money to fight counterfeiters

One of the big challenges of slowing the flow of counterfeit drugs is its international nature. Fakes may be made in China, for example, and make stops in several continents before finding their way into the legitimate supply chain.

Eli Lilly CEO endorses anti-counterfeiting campaign in China

China, considered a key global source of counterfeit drugs, has picked up a new partner in its fight to tame that problem.

Congress resurrects track and trace bill

The idea of creating a national track and trace system for the pharmaceutical supply chain is apparently alive and kicking around Congress.

Internet drug dealer gets 10 years but feds want his Chinese boss

Federal authorities have brought down a pawn but are still looking for the king of an extensive Chinese drug counterfeiting operation who slipped through their fingers last year.

China sweeps in on drug counterfeiters

In another major display of action, 18,000 Chinese police officers executed the roundup of nearly 2,000 drug counterfeiting suspects and destroyed 1,100 production plants.

India kicks track and trace further down the road

Despite increasing reports of drug counterfeiting, track and trace programs designed to help attack the problem continue to have problems getting off the ground in the face of industry opposition.

FDA commish suggests putting more bite in laws for counterfeiting

FDA Commissioner Margaret Hamburg called on drugmakers to be "accountable for the integrity of their supply chains" to help fight counterfeit drugs.

Pfizer CEO: More than 50 fakes of our drugs discovered last year

While publicity has focused on the counterfeit Avastin recently discovered in the U.S., the problem of fakes is much more widespread than the pubic realizes. Pfizer CEO Ian Read said the company confirmed more than 50 fakes of its drugs in at least 101 countries just last year.